Webcast overview
People need medical treatment and medicine in good times and bad, but healthcare and life science (HCLS) companies are not immune to economic downturns. Patients tightening their belts may forego the elective surgeries that are important sources of revenue for hospitals, with associated impacts on medical devices and pharmaceutical interventions used in these procedures.
Join us for a discussion with KPMG industry leaders as they discuss how HCLS companies have been affected by the current state of the economy, how they can stay resilient in a downturn, and how they can avoid the worst impacts and plan for new growth.
